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ABSTRACT 
 
Marine sponges (phylum Porifera) are among the oldest multicellular animals (metazoans), the sea’s 
most prolific producers of bioactive metabolites, and of considerable ecological importance due to their 
abundance and ability to filter enormous volumes of seawater. In addition to these important attributes, 
sponge microbiology is now a rapidly expanding field. Marine sponges produce numerous bioactive 
compounds with promising pharmaceutical properties. Sponges are well known to harbor diverse 
microbes and represent a significant source of bioactive natural compounds derived from the marine 
environment. Recent studies of the microbial communities of marine sponges have uncovered previously 
undescribed species and an array of new chemical compounds. Microbial symbionts in marine sponges 
offer potential sources of marine natural products and serve as marine natural product factory that 
supplies bioactive compounds in a sustainable way. 
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INTRODUCTION 
 
The ocean is a rich source of biological and 
chemical diversity.  It covers more than 70% 
of the earth’s surface and hosts more than 
300,000 described species of plants and 
animals to date with much higher numbers 
of microorganisms to be expected. This 
diversity has been the source of unique 
chemical compounds with the potential for 
industrial development as pharmaceuticals, 
cosmetics, nutritional supplements, 
molecular probes, enzymes, and 
agrichemicals.  A relatively small number of 
marine plants, animals, and microbes have 
already yielded more than 12,000 novel 
chemicalsi. The ocean represents a virtually 
unexploited resource for discovery of even 
more novel compounds with useful 
applications. 
Although the ocean represents the 
centre of biological diversity with 34 of 37 
phyla of life represented (compared to only 
17 on land), prospecting marine resources 
for biotechnological use, particularly in drug 
discovery, is a relatively recent activity. 
Unlike bioprospecting on land, marine 
bioprospecting is a relatively new 
phenomenon. Some estimates, however, 
suggest that the probability of discovering a 
drug from marine sources is approximately a 
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thousand times more than that from 
terrestrial ones. 
To date, the primary target for marine 
bioprospecting has been tropical seas.  Coral 
reefs and other highly diverse ecosystems 
such as mangroves, and seagrass have been 
targeted for bioprospecting because they 
host a high level of biodiversity and are 
often characterised by intense competition 
for space, leading to a chemical warfare 
among sessile organisms.  Coral reefs are 
some of the most productive ecosystems on 
earth, and are certainly the most productive 
and species-rich environments in the oceans.  
Marine organisms, in particular 
marine invertebrates from coral reefs have 
become sources of great interest to natural 
product chemistry, since they produce 
metabolites with different biological 
activities. Marine invertebrates, which are 
plentiful in the Indo-Pacific regions 
including Indonesia, are rich in secondary 
metabolites and are becoming targets of 
continuing search for bioactive compounds.  
 
 
MARINE SPONGES AND MARINE 
NATURAL PRODUCTS 
 
Sponges (phylum Porifera) are most 
primitive of the multicelled animals that 
have existed for 700–800 million years. Of 
the approximately 15,000 sponge species, 
most occur in marine environments. Only 
about 1% of the species inhabits freshwater 
(Belarbi et al, 2003). 
 It has been known that sponges 
produce secondary metabolites to repel and 
deter predators (Pawlik et al., 2002), 
compete for space with other sessile species 
(Davis et al., 1991; Becerro et al., 1997), 
and for communication and protection 
against infection. In addition, potentially 
therapeutic compounds identified in sponges 
include anticancer agents and 
immunomodulators. Some sponges seem to 
produce potentially useful antifouling agents 
(Hellio et al., 2005). 
Recent research progresses reported 
that many bioactive natural products from 
marine invertebrates have striking 
similarities to metabolites of their associated 
microorganisms including bacteria (Proksch 
et al, 2002; Thiel and Imhoff, 2003; Radjasa 
et al, 2007a). Thus, it is important to 
highlight the possible role of marine bacteria 
associated with sponges in providing 
solution to the problem of infection by 
pathogenic bacteria. Bacteria-sponge 
association that occurs on the sponges then 
could be of great interest to search for 
potential use as new source of bioactive 
compounds, in particular as a solution of the 
problem of supply of most bioactive 
compounds produced by reef’s invertebrates. 
In addition, the search for bioactive 
compounds from invertebrates of the coral 
reefs represents another threat for 
sustainable use of coral reef. 
In addition, it has often proven 
extremely difficult, and some cases 
impossible, to provide from invertebrates 
sufficient amounts  of these substances due 
to limited amounts found in the producing 
organism, or to limited quantity of the 
organism itself, or to geographic, seasonal or 
sexual variations in the amounts and in the 
nature of produced secondary metabolites.  
 
 
MICROBIAL SYMBIONTS IN 
MARINE SPONGES 
 
The bacteria are found associated with all 
organisms. Outstanding examples from the 
sea are the 50% bacterial biomass in 
sponges of the order Verongida, abundant 
cyanobacteria in many sponges, and 
oxychlorobacteria in colonial ascidians of 
the family Didemnidae. In the latter, 
Acaryochloris marina is an unusual 
photoautotroph based on mostly chlorophyll 
d, with only minor amounts of chlorophyll a. 
Many eukaryotic microorganisms are also 
known as symbionts of marine species, e.g. 
dinoflagellates in sponges and fungi in a 
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variety of invertebrates, algae and seagrass 
(Taylor et al, 2007).  
It has often been surmised that certain 
products isolated from marine 
macroorganisms may have microbial origin. 
Much work has also been devised to find a 
biotechnological route to therapeutically 
promising compounds isolated from rare 
marine macroorganisms, and too complex 
for a practical chemical synthesis; however, 
in only a few cases has a microbial origin 
been proven if 'dietary' metabolites are 
omitted. One of the best proven, and over-
reviewed cases concerns a brominated 
diphenyl ether isolated from both the 
tropical sponge Dysidea sp. and its 
symbiontic bacterium Vibrio sp. in culture. 
 
 
MICROBIAL  SYMBIONTS  AS 
SOURCES  OF  NATURAL  
PRODUCTS 
 
The term “symbiosis” is currently used to 
describe two different biological concepts, 
which has caused a substantial amount of 
confusion. According to the original 
definition, symbiosis is a close physical 
association between two organisms 
belonging to different species. However, in 
many later sources the term is exclusively 
applied to an association that is beneficial to 
both partners. A beneficial symbiosis is 
therefore called “mutualism” (Piel, 2004).  
Perhaps the most significant problem 
that has hampered the investigation of 
secondary metabolites produced by reef’s 
invertebrates is their low concentration.  In 
marine invertebrates many highly active 
compounds contribute to<10-6 % of the 
body-wet weight. Providing sufficient 
amounts of these biologically active 
substances, hence, may be a difficult task 
(Radjasa et al 2007a) 
Sponges are currently the most 
important marine source of biologically 
active natural products (Proksch et al, 2002). 
Many sponge derived metabolites are 
suspected to be truly produced by bacteria, 
since they resemble bacterial natural 
products or belong to substance classes 
typical for these microorganisms, such as 
complex polyketides or nonribosomal 
peptides. 
In almost all cases development and 
production of sponge-derived drugs is 
seriously hampered by the environmental 
and technical problems associated with 
collecting or cultivating large amounts of 
animals. The possible existence of 
producing bacterial symbionts is therefore 
especially intriguing, because a sustainable 
source of sponge-derived drug candidates 
could be generated by establishing a 
symbiont culture or by transferring symbiont 
biosynthetic genes into culturable bacteria. 
Table.1 and Fig.1, list some of structurally 
related sponge metabolites that resemble 
bacterial metabolites. 
 
Table 1. Structurally related microbial metabolites with sponge metabolites*) 
No Sponge  
metabolite 
Source Bacterial  
metabolite 
Source 
1 Arenastatin A   Dysidea arenaria Cryptophycin 1 Nostoc sp. 
2 Jaspamide Jaspis spp. Chondramide Chondromyces crocatus 
3 Mimosamycin Petrosia sp. Mimosamycin Streptomyces lavendulae 
4 Salicylihalamide Haliclona sp. Apicularen A Chondromyces sp. 
5 Swinholide A T. swinhoei Tolytoxin Tolypothrix sp. 
*) Adapted from Piel (2004) 
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Fig. 1 Structurally related sponge metabolite of Jaspamide (26) and microbial metabolite 
Chondramide(27) adapted from Piel (2004). 
 
CONCLUDING REMARKS 
 
In conclusion, the possible existence of 
producing bacterial symbionts is therefore 
especially intriguing, because a sustainable 
source of sponge-derived drug candidates 
could be generated by establishing a 
symbiont culture or by transferring symbiont 
biosynthetic genes into culturable bacteria. 
Marine sponges exhibited diverse secondary 
metabolite producing-marine microorganism 
with various potential against different 
diseases.  
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